Bridge City Capital’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.9M Buy
383,901
+45,193
+13% +$977K 2.07% 6
2026
Q2
$6.84M Buy
338,708
+3,603
+1% +$72.7K 1.56% 21
2026
Q1
$6.56M Buy
335,105
+99,620
+42% +$2.44M 1.82% 13
2025
Q4
$6.31M Buy
235,485
+99,227
+73% +$2.56M 1.85% 11
2025
Q3
$3.63M Sell
136,258
-2,386
-2% -$61.6K 0.97% 40
2025
Q2
$3.18M Buy
138,644
+22,789
+20% +$566K 0.89% 45
2025
Q1
$3.36M Buy
115,855
+45,760
+65% +$1.46M 1.01% 40
2024
Q4
$2.6M Sell
70,095
-984
-1% -$45K 0.69% 62
2024
Q3
$3.45M Buy
71,079
+22,133
+45% +$971K 0.95% 43
2024
Q2
$1.96M Buy
48,946
+14,173
+41% +$587K 0.66% 67
2024
Q1
$1.53M Buy
34,773
+275
+0.8% +$14.2K 0.56% 83
2023
Q4
$2.13M Buy
34,498
+11,839
+52% +$622K 0.83% 61
2023
Q3
$1.04M Sell
22,659
-155
-0.7% -$8.46K 0.53% 84
2023
Q2
$1.31M Buy
+22,814
New +$1.01M 0.62% 77

Other funds holding AMPH

Bridge City Capital's AMPH Position: Q3 2026 in Review

Bridge City Capital increased its Amphastar Pharmaceuticals (AMPH) stake by 13% in Q3 2026, buying an estimated $977K and bringing the position to 383,901 shares worth $9.9M. The position accounts for 2.07% of the portfolio, ranked #6.

Bridge City Capital first reported a position in AMPH in Q2 2023 and has held it in 14 quarters since. 59 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.

  • Bridge City Capital held 383,901 shares of Amphastar Pharmaceuticals worth $9.9M as of Q3 2026.
  • Bridge City Capital bought 45,193 Amphastar Pharmaceuticals shares in Q3 2026, an estimated $977K.
  • Amphastar Pharmaceuticals made up 2.07% of Bridge City Capital's portfolio in Q3 2026, its #6 holding.
  • Bridge City Capital first reported a position in Amphastar Pharmaceuticals in Q2 2023 and has held it in 14 quarters since.
  • 59 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.

Based on Bridge City Capital's 13F filing for Q3 2026, filed 29 Oct 2026.